AUTHORS
Stephen Guilfoyle
Recent Articles By The Author
Will Gilead Sciences Remdesivir Help Arrest the Coronavirus?
Right now, GILD holds a strictly defensive spot among my holdings.
Coronavirus Impact Spreads, Market Selloff, Fed Action, Risk Tolerance
What came first? The chicken or the egg? The bear market or the pandemic? I don't care much for labels.
There's a Worthy Options Play to Be Had With JP Morgan
I'm not willing to stick my neck out right now and take an equity stake.
Payroll Tax Holiday, Rate Cuts, Trading Thoughts and Coronavirus Winners
The Fed must find a way to create a payroll tax holiday, despite grumbling, and backstops must be in place to support small to medium businesses and the gig economy.
I'm Stirred Up Over Coca-Cola
KO pays a sustainable dividend -- and is attractive in uncertain times -- but it's exposed to breakdowns in supply chains and demand.
Navigating These Times, Putting Cash to Work, Oil Price War, Trump Stimulus Plan
Markets appear stable. Do we trust it? Can we trust it? Of course not.
An Oil Price War Is Born but I'm Not Selling BP Today
Perhaps investors would be wise to invoke the Jim Cramer 'three day rule' where energy is concerned.
The Oil Factor, 50 Year Bonds, Trading Clorox and Gilead Sciences: Market Recon
The question begs... 'Do significantly lower oil prices provoke increased demand?' Anywhere?
I Fully Intend to Add to My Long Costco Position Friday
To label COST my favorite retailer is to put it mildly.
Sick Bond Market, What's Really Bad, Airlines in a Tailspin, Trading Thoughts
Would love to know if Warren Buffett is adding here, or keeping his powder dry. Would simply love to know.
Oops!
We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.
Please Join or Log In to Email Our Authors.
Email Real Money's Wall Street Pros for further analysis and insight
Already a Subscriber? Login